Is pomegranate juice a potential perpetrator of clinical drug–drug interactions? Review of the in vitro, preclinical and clinical evidence

2013 ◽  
Vol 38 (4) ◽  
pp. 223-229 ◽  
Author(s):  
Nuggehally R. Srinivas
Keyword(s):  
Drug Interactions ◽  
Clinical Evidence ◽  
Pomegranate Juice ◽  
Clinical Drug

scholarly journals Modeling of Rifampicin-Induced CYP3A4 Activation Dynamics for the Prediction of Clinical Drug-Drug Interactions from In Vitro Data

PLoS ONE ◽  
2013 ◽  
Vol 8 (9) ◽  
pp. e70330 ◽  
Author(s):  
Fumiyoshi Yamashita ◽  
Yukako Sasa ◽  
Shuya Yoshida ◽  
Akihiro Hisaka ◽  
Yoshiyuki Asai ◽  
...  
Keyword(s):  
Drug Interactions ◽  
Activation Dynamics ◽  
Vitro Data ◽  
Clinical Drug ◽  
In Vitro Data

scholarly journals Application of in vitro CYP and transporter assays to predict clinical drug–drug interactions

Bioanalysis ◽  
2018 ◽  
Vol 10 (9) ◽  
pp. 619-623 ◽  
Author(s):  
Donna A Volpe ◽  
Praveen V Balimane
Keyword(s):  
Drug Interactions ◽  
Clinical Drug

In Vitro Approaches to Anticipating Clinical Drug Interactions

2007 ◽  
pp. 31-74
Author(s):  
Laurie P. Volak ◽  
David J. Greenblatt ◽  
Lisa L. von Moltke
Keyword(s):  
Drug Interactions ◽  
Clinical Drug

scholarly journals In Vitro and In Silico Strategies to Identify OATP1B1 Inhibitors and Predict Clinical Drug–Drug Interactions

2011 ◽  
Vol 29 (2) ◽  
pp. 411-426 ◽  
Author(s):  
Maria Karlgren ◽  
Gustav Ahlin ◽  
Christel A. S. Bergström ◽  
Richard Svensson ◽  
Johan Palm ◽  
...  
Keyword(s):  
Drug Interactions ◽  
In Silico ◽  
Clinical Drug

ITC Commentary on the Prediction of Digoxin Clinical Drug–Drug Interactions from In Vitro Transporter Assays

2014 ◽  
Vol 96 (3) ◽  
pp. 298-301 ◽  
Author(s):  
C A Lee ◽  
J C Kalvass ◽  
A Galetin ◽  
M J Zamek-Gliszczynski
Keyword(s):  
Drug Interactions ◽  
Clinical Drug
Sign in / Sign up

Export Citation Format

Share Document